Through the PI3K/AKT and ERK pathways, NETO2 stimulates proliferation and metastasis, which advances the course of esophageal cancer. IAJAVS [Internet]. 2025 Jan. 29 [cited 2026 Oct. 17];13(1):58-72. Available from: https://iajavs.org/index.php/iajavs/article/view/158